Project Resurgence Communication Trial
Status
Completed
Conditions
Communication Research
Treatments
Other: Communication type
Details and patient eligibility
About
Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.
Enrollment
11,120 patients
Sex
All
Volunteers
No Healthy Volunteers
Inclusion criteria
- Patients with a cancellation or failure to show for a procedure or visit from March 9, 2020 through June 7, 2020 (90 days) and who have not rescheduled as of the date of randomization
Exclusion criteria
- Death
Trial design
Primary purpose
Other
Allocation
Randomized
Interventional model
Factorial Assignment
Masking
Quadruple Blind
11,120 participants in 5 patient groups
No intervention
No Intervention group
MPM control letter
Active Comparator group
Treatment:
Other: Communication type
MPM intervention letter
Experimental group
Treatment:
Other: Communication type
Mailed control letter
Active Comparator group
Treatment:
Other: Communication type
Mailed intervention letter
Experimental group
Treatment:
Other: Communication type
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems